U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.656A>C (p.Glu219Ala) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 22, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002017313.4

Allele description [Variation Report for NM_000372.5(TYR):c.656A>C (p.Glu219Ala)]

NM_000372.5(TYR):c.656A>C (p.Glu219Ala)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.656A>C (p.Glu219Ala)
HGVS:
  • NC_000011.10:g.89178609A>C
  • NG_008748.1:g.5738A>C
  • NM_000372.5:c.656A>CMANE SELECT
  • NP_000363.1:p.Glu219Ala
  • NC_000011.9:g.88911777A>C
Protein change:
E219A
Links:
dbSNP: rs2135242551
NCBI 1000 Genomes Browser:
rs2135242551
Molecular consequence:
  • NM_000372.5:c.656A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002287564Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 22, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.

Chaki M, Sengupta M, Mukhopadhyay A, Subba Rao I, Majumder PP, Das M, Samanta S, Ray K.

Ann Hum Genet. 2006 Sep;70(Pt 5):623-30.

PubMed [citation]
PMID:
16907708

Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients.

Chaki M, Sengupta M, Mondal M, Bhattacharya A, Mallick S, Bhadra R; Indian Genome Variation Consortium., Ray K.

J Invest Dermatol. 2011 Jan;131(1):260-2. doi: 10.1038/jid.2010.274. Epub 2010 Sep 23. No abstract available.

PubMed [citation]
PMID:
20861851
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002287564.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 219 of the TYR protein (p.Glu219Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TYR-related conditions. ClinVar contains an entry for this variant (Variation ID: 1501231). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. This variant disrupts the p.Glu219 amino acid residue in TYR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16907708, 20861851, 31077556). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024